Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)
Status:
Terminated
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
Breast cancer patients who smoke, are at greater risk for treatment complications. The
purpose of this study is to see if the researchers can find ways to help patients who have
breast cancer quit smoking. They will compare two ways to help people quit smoking. Some
patients will receive varenicline, a prescription medicine also known as Chantix,®. Other
patients will receive a placebo drug. A placebo is an inactive substance that contains no
medicine. All patients will receive smoking cessation counseling provided by our tobacco
treatment specialists. They hope that what the researchers learn from this study will help us
improve our smoking cessation treatment program for breast cancer patients.